{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "Patient had an anterior-wall myocardial infarction and emergency PCI in 2009.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0027051",
              "label": "Myocardial Infarction",
              "status": "historical",
              "onset_date": "2009"
            }
          ],
          "procedures": [
            {
              "name": "C0030682",
              "approach": "percutaneous",
              "date": "2009",
              "location": "anterior wall",
              "performed_by": "unknown",
              "outcome": "unknown"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient underwent surgery for hernia in Spring 2022.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Hernia repair",
              "date": "2022"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "May 2022 (week 0): Patient presented with pain in the left flank and groin, and tenderness in the left axilla/hemi-thorax. CT thorax showed four potentially malignant lesions dorsolaterally in the right lower lobe, with signs of infiltration of the thoracic wall and enlarged mediastinal lymph nodes. CT abdomen showed multiple liver metastases; the largest with a diameter of 5.5 cm. Largest pulmonary lesions were 3x1.5 cm and 2x2 cm. Ultrasound-guided liver biopsy revealed extensive stage small cell lung cancer (ES-SCLC). ECOG performance status 0.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient presented with pain in the left flank and groin, and tenderness in the left axilla/hemi-thorax.",
              "onset": "May 2022"
            }
          ],
          "imaging": [
            {
              "type": "lesion",
              "body_part": "lung",
              "modality": "CT",
              "finding": "four potentially malignant lesions dorsolaterally in the right lower lobe, with signs of infiltration of the thoracic wall and enlarged mediastinal lymph nodes",
              "date": "2022-05"
            },
            {
              "type": "metastasis",
              "body_part": "liver",
              "modality": "CT",
              "finding": "multiple liver metastases; the largest with a diameter of 5.5 cm",
              "date": "2022-05"
            }
          ],
          "diagnoses": [
            {
              "code": "C0684272",
              "label": "small cell lung cancer",
              "status": "active",
              "onset_date": "2022-05"
            }
          ],
          "functional_status": [
            {
              "domain": "general",
              "description": "ECOG performance status 0",
              "score": "0",
              "scale": "ECOG"
            }
          ]
        },
        "timestamp": "2022-05"
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Week 0: Durvalumab treatment cycle 1, Etoposid/Carboplatin treatment cycle 1, S-NSE 48 \u00b5g/L (reference <16), GABA-BR1/2 serum 1/1000, GAD65 serum Negative, HbA1c 41 mmol/mol.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Durvalumab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "Etoposide",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "Carboplatin",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "labs": [
            {
              "test": "S-NSE",
              "value": "48",
              "unit": "\u00b5g/L",
              "flag": "abnormal",
              "reference_range": "<16",
              "timestamp": null
            },
            {
              "test": "GABA-BR1/2 serum",
              "value": "1/1000",
              "unit": null,
              "flag": "unknown",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "GAD65 serum",
              "value": "Negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "HbA1c",
              "value": "41",
              "unit": "mmol/mol",
              "flag": "unknown",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Week 4: Durvalumab treatment cycle 1, Etoposid/Carboplatin treatment cycle 1, GABA-BR1/2 serum 1/1000, GAD65 serum Negative, HbA1c 46 mmol/mol.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Durvalumab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "Etoposide",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "Carboplatin",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "labs": [
            {
              "test": "HbA1c",
              "value": "46",
              "unit": "mmol/mol",
              "flag": null,
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Week 6: Partial response to treatment.",
        "clinical_data": {}
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Week 8: Durvalumab treatment cycle 1, Etoposid/Carboplatin treatment cycle 1, ECOG score 1-2 (COVID-",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0013928",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0019274",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0007279",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "functional_status": [
            {
              "domain": "ADLs",
              "description": "ECOG score 1-2",
              "score": "1-2",
              "scale": "ECOG"
            }
          ],
          "diagnoses": [
            {
              "code": "UMLS:C4720922",
              "label": "COVID-19",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Time elapsed between myocardial infarction/PCI in 2009 and hernia surgery in Spring 2022."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Time elapsed between hernia surgery in Spring 2022 and presentation with left flank/groin pain in May 2022.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "symptom",
          "timestamp": "2022-05"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Initiation of treatment for extensive stage small cell lung cancer (ES-SCLC).",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0013928",
            "C0019274",
            "C0007279"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Four weeks of treatment with Durvalumab, Etoposide, and Carboplatin.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "HbA1c"
          ],
          "change_type": "progression",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Two weeks elapsed.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Two weeks elapsed, patient now has COVID-19 and ECOG score of 1-2.",
        "transition_event": {
          "trigger_type": "diagnosis",
          "trigger_entities": [
            "UMLS:C4720922"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    }
  ]
}